Klaus Jung
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
- Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Cancer Research 129
- MicroRNA in disease regulation 42
- Protease and Inhibitor Mechanisms 40
-
- Prostate Cancer Treatment and Research 131
- Prostate Cancer Diagnosis and Treatment 96
- Co-authors
- Carsten StephanMichael LeinGlen KristiansenStefan A. LoeningDietmar SchnorrMonika JungEleftherios P. DiamandisKurt Miller
- Journals
- Clinical Chemistry (43 papers)The Prostate (24 papers)Clinica Chimica Acta (21 papers)The Journal of Urology (20 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (19 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Klaus Jung
576 papers receiving 19.2k citations
Hit Papers
Peers
Comparison fields: 5 of 201
- Cancer Research 5.6k
- Pulmonary and Respiratory Medicine 4.9k
- Molecular Biology 8.7k
- Oncology 3.4k
- Nephrology 842
Countries citing papers authored by Klaus Jung
This map shows the geographic impact of Klaus Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Jung more than expected).
Fields of papers citing papers by Klaus Jung
This network shows the impact of papers produced by Klaus Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Jung. The network helps show where Klaus Jung may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Jung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 1 | |
| 4 | 2020 | 5 | |
| 5 | 2020 | 21 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 5 | |
| 8 | 2017 | 7 | |
| 9 | 2015 | 167 | |
| 10 | 2015 | 5 | |
| 11 | 2012 | 76 | |
| 12 | 2011 | 29 | |
| 13 | 2008 | 2 | |
| 14 | 2006 | 19 | |
| 15 | mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue. | 2003 | 15 |
| 16 | Stable isotope tracer technique as a tool to increase the sensitivity of plant growth bioassays - investigations with Pentachlorophenol and Trichloroacetic acid. | 2000 | 3 |
| 17 | 1997 | 83 | |
| 18 | 1997 | 3 | |
| 19 | 1993 | 25 | |
| 20 | [Influence of temperature on enzyme activity determination in serum : L-aspartate aminotransferase isoenzymes]. | 1975 | 0 |
About Klaus Jung
Klaus Jung is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Clinical Biochemistry, Nephrology and Immunology and Allergy, having authored 594 papers that have together received 19.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (131 papers), Prostate Cancer Diagnosis and Treatment (96 papers), MicroRNA in disease regulation (42 papers), Protease and Inhibitor Mechanisms (40 papers), Peptidase Inhibition and Analysis (35 papers), Metabolism and Genetic Disorders (32 papers), Molecular Biology Techniques and Applications (32 papers) and Circular RNAs in diseases (28 papers). The work is most often cited by research in Cancer Research (5.6k citations), Pulmonary and Respiratory Medicine (4.9k citations), Molecular Biology (8.7k citations), Oncology (3.4k citations) and Nephrology (842 citations). Klaus Jung has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Carsten Stephan, Michael Lein, Glen Kristiansen, Stefan A. Loening, Dietmar Schnorr, Monika Jung, Eleftherios P. Diamandis, Kurt Miller, Wolfgang Henke and George M. Yousef. Their work appears in journals such as Clinical Chemistry, The Prostate, Clinica Chimica Acta, The Journal of Urology and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.